In 2023, digital health fundraising took on a bit of a different shape, according to a new Rock Health report. Startups tried out some creative ways to keep their businesses afloat — including series extension rounds, unlabeled fundraises and silent deals from existing investors.
Commons Clinic — a value-based physician group providing musculoskeletal care to patients in the Los Angeles area — announced the launch of its Center for Spine Economics, Outcomes & Research. The center will research and test new models that move spinal care out of the hospital and into community-based accountable care networks. The startup plans to invest $100 million in the center over the next decade.
Quantum Health's Chief Product Officer, Dan Shur talks about the company’s recent Index Report on the changing landscape of healthcare consultants.
Each track will spotlight a different specialty area including: oncology, cardiology, women's health and preventing burnout/supporting operational efficiency.
Check out news from Kismet Health, the University of California at Berkeley's life science startups, and the companies presenting at the Consumer Technology Association's pitch contest at CES.
Contraline released promising data from the clinical trial it’s conducting to test the efficacy of Adam, its male birth control product. The nonhormonal gel seems to be doing a good job of blocking the flow of sperm to the vas deferens, and no serious adverse events have been reported.
Goldman Sachs’s new fund—its first dedicated to life sciences—will focus on early- to mid-stage therapeutics companies with multiple assets. Genetic medicine, cell therapy, immunotherapy, and artificial intelligence are among the areas of investment interest for the firm.
Chief Medical Officer, Dr. Mark Pratt of Altera Digital Health addresses the way technology can be leveraged to improve healthcare in rural communities.
Medical device startup CardioMech raised $13 million to advance the development and validation of its flagship device, which is designed to treat degenerative mitral valve regurgitation. The catheter-based device seeks to offer an uncomplicated, direct procedure for patients eligible for open-heart surgery as well as those considered eligible for the surgery.
Guidehealth, a nascent value-based care enablement startup, acquired Arcadia’s value-based care service division. Acquiring this business unit allows Guidehealth to provide health systems with a platform that helps them succeed in value-based care arrangements while still maintaining their patient volume levels.
Healthcare's share of the global PE and VC deal count will likely continue decreasing in 2024, according to a new Pitchbook report. The report also predicted that generative AI and surgical robotics will continue to be hot areas of interest for investors, and that there will be at least three digital health IPOs next year.
This week, check out news from Alpha Sophia, Encellin, CalmWave, Essential AI, and MATTER.
CEO of Cohere Health, Siva Namasivayam details how the company provides technology to streamline the prior authorization process.
There are a lack of women at venture capital firms. This makes it difficult for women's health startups focused on stigmatized conditions to get funding when pitching to those who don't always have a good understanding, startups say.
Twin Health raked in $50 million in Series D financing. The startup seeks to help patients improve their metabolic health and reduce the need for medications through the “digital twin” technology it sells to employers and health plans.
Check out news from FreezeNit, Vascular Perfusion Solutions, Kandu, and BetterYou.
MedKitDoc Founder Dorian Koch shared the journey of the startup, which wants to transform the way patients receive healthcare.
CB Insights released a list of what it deems to be the 50 most promising digital health companies of 2023. The market research firm said that the startups on the list are working to improve four main aspects of healthcare: personalization, efficiency, equity and accessibility.